Press Releases

Blockbuster Potential in Perimenopause with new E4 Candidate and Acceleration of Donesta Phase III Program
7 January 2019
EN FR

Mithra Announces Attendance at the 37th Annual J.P. Morgan Healthcare Conference
4 January 2019
EN FR

Mithra Announces Complex Therapeutics Update
21 December 2018
EN FR

Mithra Announces Myring™ Update
14 December 2018
EN FR

Mithra Announces Positive Results of Ovarian Function Sub-Study which Strengthens Estelle® Contraceptive Efficacy Profile
6 December 2018
EN FR

Mithra Reduces Environmental Impact of CDMO facility in Belgium with the Installation of 1800 Solar Panels
21 November 2018
EN FR

Mithra Signs Exclusive License and Supply Agreement for Vaginal Contraceptive Ring in Australia and New Zealand
20 November 2018
EN FR

Full Estetrol (E4) Program Update Provided at Scientific Advisory Board Meetings
19 November 2018
EN FR

Mithra Announces the Completion of its Lead Clinical Phase III Programme for Estelle®
14 November 2018
EN FR

New Warrant Plan Approved by Mithra Shareholders
6 November 2018
EN FR

Mithra Signs Exclusive License and Supply Agreement with Adcock Ingram for Commercialization of Estelle® in Southern Africa
30 October 2018
EN FR

2018 Update and 2019 Outlook Given at the CPHI Conference
10 October 2018
EN FR